Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs TXA in Endoscopic Sinus Surgery
NCT05639686Unknown
- Sponsor
- Our Lady of the Lake Regional Medical Center
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in chronic rhinosinusitis (CRS), Sinonasal cancer, nasal polyps and 1 more (2 arms), sponsored by Our Lady of the Lake Regional Medical Center. Primary endpoints: Surgical Field Quality and Intraoperative Blood Loss. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
chronic rhinosinusitis (CRS)Sinonasal cancernasal polypsencephalocele
Beyond the preview
Go deeper on NCT05639686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05639686.